STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — SpringWorks Therapeutics Inc. (SWTX) on Tuesday reported a loss of $74.2 million in its fourth quarter.
On a per-share basis, the Stamford, Connecticut-based company said it had a loss of $1.19.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.21 per share.
For the year, the company reported a loss of $277.4 million, or $5.21 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a SWTX">Zacks stock report on SWTX at https://www.zacks.com/ap/SWTX